Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 155Neoplasms 113Carcinoma, Non-Small-Cell Lung 86Prostatic Neoplasms 84Colorectal Neoplasms 84Lung Neoplasms 72Carcinoma, Hepatocellular 51Leukemia, Myeloid, Acute 49Pancreatic Neoplasms 46Neoplasm Metastasis 41Multiple Myeloma 37Recurrence 35Triple Negative Breast Neoplasms 28Melanoma 28Squamous Cell Carcinoma of Head and Neck 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Ovarian Neoplasms 27Head and Neck Neoplasms 27Glioblastoma 27Brain Neoplasms 26Uterine Cervical Neoplasms 25Stomach Neoplasms 24Small Cell Lung Carcinoma 24Rectal Neoplasms 24Endometrial Neoplasms 21Carcinoma, Renal Cell 21Lymphoma, Follicular 20Lymphoma, B-Cell 19Lymphoma 19Motor Activity 17

Interventions

Watchful Waiting 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Neuroendocrine Tumors (pNET) × 90 days × Clear all
NCT07591493 2026-05-15

ADJUPANET

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Not yet recruiting
300 enrolled
EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors (pNET)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡